Position in AKBA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$110,625
-$15,896 QoQ
Shares Held
79,587
+71.7% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AKBA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Engineers Gate Manager LP holds $37,099,989 across 27 Drug Manufacturers - Specialty & Generic names. AKBA ranks #24 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
338,218 | $8,093,556 | |
| 2 | ALKS |
Alkermes plc.
|
208,497 | $7,372,453 | |
| 3 | VTRS |
Viatris Inc
|
167,699 | $2,265,613 | |
| 4 | LQDA |
Liquidia Corp
|
53,625 | $2,023,807 | |
| 5 | BCRX |
Biocryst Pharmaceuticals Inc
|
194,475 | $1,851,402 | |
| 6 | COLL |
Collegium Pharmaceutical, Inc
|
49,814 | $1,647,348 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
11,198 | $1,475,224 | |
| 8 | PAHC |
Phibro Animal Health Corp
|
24,862 | $1,375,117 |
All Filings in AKBA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $110,625 | 79,587 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $126,521 | 46,345 | Shares | Sole | 2025-11-14 | |
| 2021-12-31 | $180,962 | 80,072 | Shares | Sole | 2022-02-14 | |
| 2020-12-31 | $124,040 | 44,300 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $481,920 | 192,000 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||